Real‐world prognosis of eyes with diabetic macular oedema receiving treatment with vascular endothelial growth factor (VEGF) inhibitors
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Real‐world Prognosis of Eyes With Diabetic Macular Oedema Receiving Treatment With Vascular Endothelial Growth Factor (VEGF) Inhibitors." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435846/0/images/tooltip-triangle.png. Accessed 02 May 2024.
Real‐world prognosis of eyes with diabetic macular oedema receiving treatment with vascular endothelial growth factor (VEGF) inhibitors. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435846/0/images/tooltip-triangle.png. Accessed May 2, 2024.
Real‐world prognosis of eyes with diabetic macular oedema receiving treatment with vascular endothelial growth factor (VEGF) inhibitors. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/435846/0/images/tooltip-triangle.png
Real‐world Prognosis of Eyes With Diabetic Macular Oedema Receiving Treatment With Vascular Endothelial Growth Factor (VEGF) Inhibitors [Internet]. In: Cochrane Abstracts. [cited 2024 May 02]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435846/0/images/tooltip-triangle.png.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Real‐world prognosis of eyes with diabetic macular oedema receiving treatment with vascular endothelial growth factor (VEGF) inhibitors
ID - 435846
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435846/0/images/tooltip-triangle.png
DB - Evidence Central
DP - Unbound Medicine
ER -